References
- Pohani G, Zou S, Tepper M. Trends of hepatitis B and hepatitis C mortality in Canada, 1979–1997. Can J Public Health 2001; 92: 250–4
- Remis R. A study to characterize the epidemiology of hepatitis C infection in Canada, 2002 Report to Health Canada. 2002.
- Gully PR, Tepper ML. Hepatitis C. CMAJ 1997; 156: 1427–30
- Roy E, Haley N, Leclerc P, Boivin JF, Cedras L, Vincelette J. Risk factors for hepatitis C virus infection among street youths. CMAJ 2001; 165: 557–60
- Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart ML, et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ 2001; 165: 889–95
- Bowker SL, Soskolne CL, Houston SC, Newman SC, Jhangri GS. Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) in a northern Alberta population. Can J Public Health 2004; 95: 188–92
- Alter MJ, Seeff LB, Bacon BR, Thomas DL, Rigsby MO, Di Bisceglie AM. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Ann Intern Med 2004; 141: 715–7
- Goldberg D, Anderson E. Hepatitis C: who is at risk and how do we identify them?. J Viral Hepat 2004; 11((Suppl 1))S12–8
- Sockett PN, Garnett MJ, Scott C. Communicable disease surveillance: notification of infectious disease in Canada. Can J Infect Dis 1996; 7: 293–5
- Zou S, Zhang J, Tepper M, Giulivi A, Baptiste B, Predy G, et al. Enhanced surveillance of acute hepatitis B and C in 4 regions in Canada, 1998 to 1999. Can J Infect Dis 2001; 12: 357–63
- Alter MJ. Non-A, non-B hepatitis: sorting through a diagnosis of exclusion. Ann Intern Med 1989; 110: 583–5
- Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, et al. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1991–2000. CMAJ 2003; 169: 767–73
- Alter MJ. Hepatitis C virus infection in the United States. J Hepatol 1999; 31(Suppl 1)S88–91
- Ramsay ME, Balogun MA, Collins M, Balraj V. Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992 to 1996. Commun Dis Public Health 1998; 1: 89–94
- Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, Zankel M, et al. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 2001; 345: 1452–7
- Dore GJ, Law MG, Kaldor JM. Prevalence of hepatitis C virus infection in the United States. N Engl J Med 1999; 341: 2093–4
- Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology. 2002; 36(Suppl 1)S99–105
- Balogun MA, Ramsay ME, Parry JV, Donovan L, Andrews NJ, Newham JA, et al. A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection. Sex Transm Infect 2003; 79: 301–6
- Nieuwenhuis RF, Ossewaarde JM, Götz HM, Dees J, Thio HB, Maarten Thomeer MG, et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in the Netherlands among men who have sex with men. Clin Infect Dis 2004; 39: 996–1003
- Kropp RY Wong T, Canadian LGV Working Group. Emergence of lymphogranuloma venereum in Canada CMAJ 2005;172:1674–6.
- Götz HM, van Doornum G, Niesters HG, den Hollander JG, Thio HB, de Zwart O. A cluster of acute hepatitis C virus infection among men who have sex with men: results from contact tracing and public health implications. AIDS 2005; 19: 969–74